![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Flamel Technologies Announces Payment From Bristol-Myers Squibb
Flamel Technologies Announces Payment From Bristol-Myers Squibb
Flamel Technologies has entered into an agreement with Bristol-Myers Squibb, which resolves all outstanding matters with respect to the former licensing agreement dated Aug. 26, 2003, between the companies for Flamel's formulation of long-acting human insulin, Basulin. Under the terms of the agreement, Flamel will receive a cash payment, as well as clear title to certain data produced in connection with the relationship between the parties, including the results of a Phase IIa study of Basulin.
Yahoo News (http://biz.yahoo.com/bw/050131/315377_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct